Correlation Between Endocan Corp and Sherwin Williams

Can any of the company-specific risk be diversified away by investing in both Endocan Corp and Sherwin Williams at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Endocan Corp and Sherwin Williams into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Endocan Corp and Sherwin Williams Co, you can compare the effects of market volatilities on Endocan Corp and Sherwin Williams and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Endocan Corp with a short position of Sherwin Williams. Check out your portfolio center. Please also check ongoing floating volatility patterns of Endocan Corp and Sherwin Williams.

Diversification Opportunities for Endocan Corp and Sherwin Williams

0.38

Correlation Coefficient

Endocan Corp  Sherwin Williams

Weak diversification

The 3 months correlation between Endocan and Sherwin is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Endocan Corp and Sherwin Williams Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sherwin Williams and Endocan Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Endocan Corp are associated (or correlated) with Sherwin Williams. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sherwin Williams has no effect on the direction of Endocan Corp i.e., Endocan Corp and Sherwin Williams go up and down completely randomly.

Pair Corralation between Endocan Corp and Sherwin Williams

Given the investment horizon of 90 days Endocan Corp is expected to generate 98.99 times more return on investment than Sherwin Williams. However, Endocan Corp is 98.99 times more volatile than Sherwin Williams Co. It trades about 0.12 of its potential returns per unit of risk. Sherwin Williams Co is currently generating about 0.01 per unit of risk. If you would invest  0.01  in Endocan Corp on December 28, 2024 and sell it today you would earn a total of  0.00  from holding Endocan Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.36%
Values	Daily Returns

Endocan Corp  vs.  Sherwin Williams Co

Endocan Corp

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Endocan Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile fundamental indicators, Endocan Corp displayed solid returns over the last few months and may actually be approaching a breakup point.

Sherwin Williams

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sherwin Williams Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable technical indicators, Sherwin Williams is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Endocan Corp and Sherwin Williams

The main advantage of trading using opposite Endocan Corp and Sherwin Williams positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Endocan Corp position performs unexpectedly, Sherwin Williams can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sherwin Williams will offset losses from the drop in Sherwin Williams' long position.

The idea behind Endocan Corp and Sherwin Williams Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.